Literature DB >> 2587609

Variation of nicotinic binding sites among inbred strains.

M J Marks1, E Romm, S M Campbell, A C Collins.   

Abstract

The specific binding of L-nicotine and alpha-bungarotoxin, two ligands which label different populations of putative nicotinic receptors, was determined in eight brain regions of 19 inbred mouse strains. The dissociation constants for L-nicotine (average = 2.26 nM) and alpha-bungarotoxin (average = 0.31 nM) did not vary significantly among the brain regions or strains. In contrast, significant variability among the maximal binding sites was observed between regions and among the strains within a region. Significant differences in L-nicotine binding were observed among the strains in midbrain, hindbrain, hippocampus, hypothalamus and colliculi, while little variability was noted in cortex or cerebellum. In general, those strains that had high L-nicotine binding in one region had high nicotine binding in the other regions. The strains clustered into two large groups: one group expressing relatively low binding and a second group expressing relatively high binding. Significant differences in alpha-bungarotoxin binding were observed in seven of the eight regions measured and, in general, those strains with high binding in one region tended to have high binding in the other regions. The strains clustered into three groups: those with low binding (DBA/1 and DBA/2), those with high binding (ST/b alone) and those with intermediate binding (the remaining 16 strains). The amount of binding of the two ligands did not correlate with each other. Comparison of nicotinic ligand binding with physiological response to nicotine suggests a relationship of L-nicotine binding with several responses observed after injection of low doses of nicotine and a relationship between alpha-bungarotoxin binding and nicotine-induced seizures.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2587609     DOI: 10.1016/0091-3057(89)90407-3

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  28 in total

Review 1.  Mouse models for studying genetic influences on factors determining smoking cessation success in humans.

Authors:  F Scott Hall; Athina Markou; Edward D Levin; George R Uhl
Journal:  Ann N Y Acad Sci       Date:  2012-02       Impact factor: 5.691

2.  Coantagonism of glutamate receptors and nicotinic acetylcholinergic receptors disrupts fear conditioning and latent inhibition of fear conditioning.

Authors:  Thomas J Gould; Michael C Lewis
Journal:  Learn Mem       Date:  2005 Jul-Aug       Impact factor: 2.460

Review 3.  Elevation of intracellular calcium levels in neurons by nicotinic acetylcholine receptors.

Authors:  M M Rathouz; S Vijayaraghavan; D K Berg
Journal:  Mol Neurobiol       Date:  1996-04       Impact factor: 5.590

Review 4.  Adolescent brain maturation and smoking: what we know and where we're headed.

Authors:  David M Lydon; Stephen J Wilson; Amanda Child; Charles F Geier
Journal:  Neurosci Biobehav Rev       Date:  2014-07-12       Impact factor: 8.989

5.  Genetic knockout of the α7 nicotinic acetylcholine receptor gene alters hippocampal long-term potentiation in a background strain-dependent manner.

Authors:  Ronald K Freund; Sharon Graw; Kevin S Choo; Karen E Stevens; Sherry Leonard; Mark L Dell'Acqua
Journal:  Neurosci Lett       Date:  2016-05-24       Impact factor: 3.046

6.  Early-adolescent male C57BL/6J and DBA/2J mice display reduced sensitivity to acute nicotine administration.

Authors:  C N Miller; M J Caruso; H M Kamens
Journal:  Neurosci Lett       Date:  2018-10-10       Impact factor: 3.046

7.  The smoking cessation drug varenicline improves deficient P20-N40 inhibition in DBA/2 mice.

Authors:  Kristin M Wildeboer-Andrud; Karen E Stevens
Journal:  Pharmacol Biochem Behav       Date:  2011-07-07       Impact factor: 3.533

8.  Nicotinic systems and cognitive function.

Authors:  E D Levin
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 9.  Genetic variability in nicotinic acetylcholine receptors and nicotine addiction: converging evidence from human and animal research.

Authors:  George S Portugal; Thomas J Gould
Journal:  Behav Brain Res       Date:  2008-05-16       Impact factor: 3.332

10.  Nicotine self-administration in mice is associated with rates of nicotine inactivation by CYP2A5.

Authors:  Eric C K Siu; Dieter B Wildenauer; Rachel F Tyndale
Journal:  Psychopharmacology (Berl)       Date:  2006-01-28       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.